| Institutions |
Authors |
Share |
|
Boehringer Ingelheim Pharmaceuticals, Inc., United States of America (USA)
|
3.000000
|
0.18 |
|
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
|
2.000000
|
0.12 |
|
Michigan Medicine, U-M, United States of America (USA)
|
2.000000
|
0.12 |
|
The University of Texas MD Anderson Cancer Center, United States of America (USA)
|
1.000000
|
0.06 |
|
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)
|
1.000000
|
0.06 |
|
University of Bari Aldo Moro (UniBA), Italy
|
1.000000
|
0.06 |
|
The First Affiliated Hospital of Nanchang University, China
|
1.000000
|
0.06 |
|
Boehringer Ingelheim International GmbH, Germany
|
1.000000
|
0.06 |
|
Hannover Medical School (MHH), Germany
|
1.000000
|
0.06 |
|
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China
|
1.000000
|
0.06 |
|
Catholic University of Leuven (KU Leuven), Belgium
|
0.500000
|
0.03 |
|
University Hospitals Leuven (UZ Leuven), Belgium
|
0.500000
|
0.03 |
|
Christchurch Hospital, New Zealand
|
0.333333
|
0.02 |
|
New Zealand Clinical Research, New Zealand
|
0.333333
|
0.02 |
|
University of Otago, New Zealand
|
0.333333
|
0.02 |
|
Royal Brisbane and Women's Hospital (RBWH), Australia
|
0.250000
|
0.01 |
|
The University of Queensland (UQ), Australia
|
0.250000
|
0.01 |
|
Queensland Health, Australia
|
0.250000
|
0.01 |
|
QIMR Berghofer Medical Research Institute, Australia
|
0.250000
|
0.01 |
